Introduction
ln the last decade of biological research dominated by the pursuit of genomic sequence of organisms, the genus Mycobacterium has not been left behind. ln fact, several species of mycobacteria have been or are currently being sequenced to aid in the prevention and treatment of diseases such as leprosy and tuberculosis in humans and Johne's disease and tuberculosis in cattle. 1 -3 The sequences of the virulent M. tuberculosis H37Rv, avirulent fast growing M. smegmatis and that of the slow-growing M. leprae are a valuable data set for comparative studies on physiology and virulence of mycobacteria. Unraveling the genetics of essential biosynthetic pathways is the preferred approach for identifying new dug targets and has already yielded several candidates. 4 The sequencing of the M. leprae bacterium is especially significant to medicine because it gives the genetic blue print of an organism yet to be cultivated in a laboratory. The sequence has revealed 'a decaying genome' with a dramatic loss of functional capacity by mutations that gave rise to 1116 pseudogenes in every aspect of central and intermediary metabolism resulting in the obligate in vivo and intracellular habitat of M. leprae I , S (see also ' The decaying genome of My cobacterium leprae', this issue). The very long doubling time of 11-12 days 6 and the preference for a cooler environment (30°C) 7 may also be due the presence of temperature sensitive mutations in some of the remaining 1600 or so genes. Neverthe1ess, M. leprae can sustain growth and cause disease. The survival of mycobacteria under unfavorable conditions has been attributed to the characteristic permeability barrier of the cell envelope and its role in infection of host macrophages and modulation of immune responses. 8 The properties of the cell envelope are particularly relevant for M. leprae, because the organism may depend on the host for several nutrients due to defects in the synthesis of methionine, cysteine, purine rings, and uptake of several amino acids, ions and sugars l , S (see also ' The microbial physiologist' s guide to the leprosy genome', this issue). ln this report we have therefore analyzed the impact of the genome down sizing and decay on the cell wall of M. leprae. We have compared the genomes of M. leprae and M. tuberculosis and assume that genes for the biosynthesis of similar molecules are orthologous (same gene in different genomes) or at least homologous (similar gene) and those genes that are present in M. tuberculosis, but absent or pseudogenes in M. leprae are probably not involved in these syntheses or are redundant (spare). We refer the readers to the reviews by Brennan Morphology of M. leprae and the ultrastructure of the cell wall M. leprae is a strongly acid fast staining rod 1-8 ftm 10ng and 0.3 ftm in diameter and thus does not differ remarkably from M. tuberculosis. Studies of the ultrastructure of M. leprae, in sections and as whole bacteria from man, mouse and armadillo, have been extensive l s , but have not shown any gross unique features compared to other mycobacteria. However, Draper l 6 has described three ultrastructural features of the cell walls that may be character istic of M. leprae: aberrant morphology, wall bands and paracrystalline bodies. He had observed departure from the classical cylindrical shape of a bacillus in suspensions prepared from armadillos, in that ce1ls typically have a tapered or double-tapered shape with hemispherical ends, which he attributed to a defect in the normal process of cell wall construction. Wall bands first observed by Nishiura et ai. are described as 'circurnferential ridges on the outer surface of the cell', very numerous and positioned at random along the length of the cell. 1 7 These may be scars left when the cell wall separated during the division process and their randomness may reflect a defect in the cell wall construction. The paracrystalline, quasi-crystalline bodies seen in sectioned M. leprae 18 probably correspond to the capsular matrices and foamy structures responsible for binding hundreds of bacilli into 'c1umps' or globi and into smaller c1umps where the individual cells occur in parallel arrays, the noted 'bundles of cigars'.
Biochemical structure and composition
Current knowledge on the biosynthesis and genetics of several components of the myco bacterial cell wall that are described below has evolved primarily from studies with M. smegmatis, M. tuberculosis, M. bovis BCG and M. avium using a combination of methods inc1uding chemical and structural analysis, metabolic labeling, cell free assay systems, isolation and characterization of naturally occurring variants or mutants and, more recently, genetic manipulation such as mutagenesis of the genome and recombinant gene expression. However, such opportunities are limiting for M. leprae research due to the inability to cultivate the organism in vitro and the lack of proven genetic tools. Despite these limitations, sufficient information was gathered on the chemical and structural composition using small amounts of ce1ls obtained from animal or human sources to conc1ude that the basic architecture of the cell wall is the covalently linked peptidoglycan-arabinogalactan-mycolic acids complex (mAGP) seen amongst all mycobacteria and the related corynebacteria and nocardia, except for few modifications. 1 9 , 2 0
The peptidoglycan (PG) of M. leprae is characteristic of the chemotype IV group that inc1udes mycobacteria, corynebacteria and nocardia because they contain meso-diaminopi melic acid (DAP) , in the peptide chains. 8 The murarnic acids of the sugar backbone are modified with N-glycolyl rather than N-acetyl groups in mycobacteria and nocardia. 8 A feature unique to M. leprae is the substitution of L-ala with glycine in the peptide of peptidoglycan. The a-alkyl branch of the a-alkyl, ,l3-hydroxy fatty acids called mycolic acids which range from C 14 to C 26 , is C 2 0 in M. leprae. 11 The ,l3-hydroxy (meromycolate) chain is often modified with double bonds (cis and trans), cyc1opropane, methyl, epoxy, keto, and methoxy groups that render flexibility (fluidity) to the wall. M. leprae does not have methoxymycolates 26 due to the lack of a functional mmaA3 gene, as demonstrated in Mycobacterium bovis BCG (Pasteur) ?7 It appears that ketomycolates have a more specific role for growth in macro phages in M. tuberculosis as their abundance increases 5-fold in vivo, and under low oxygen tensions in vitro while the methoxymycolates decrease 2-fold. The absence of ketomycolates reduces ability to survive in macrophage like cell lines. 2 8 Therefore, the lack of methoxy mycolates in M. leprae may not impair viability in macrophages.
ln addition to the mycolates esterified to AG, mycolic acids are also present in the extractable lipids as esters of trehalose: 6-0-mycolyl and 6, 6' -O-dimycolyl trehalose (TMM and TDM respectively). Small amounts of TMM but not TDM were identified in M. leprae ? 9 The wall of M. leprae is also endowed with an unusually abundant proportion of the extractable intercalated lipoglycans, phosphatidylinositol mannosides (PIMs), lipomannans (LM) and lipoarabinomannans (LAM) characterized in several mycobacteria which may be anchored in the plasma membrane via the acyl chains (tuberculostearic and palmitic acid) of phosphatidyl inositol (PI). 30 LM and LAM are made up of linear ex-I-6 linked mannan chain originating from PIM 2 in which each mannose is further branched with ex-I-2 D-mannose ? l LAM is a heterogeneous macromolecule arising from LM that contains arabinan branches similar in composition and structure to that of AG that may be terminated with 'caps' of variable numbers of mannose or inositol residues. 10 . 32 The LAM of M. leprae has fewer Ara 6 termini, and a lesser degree of mannose capping than that of M. tuberculosis.
However, there are other solvent extractable components 8 such as glycopeptidolipids (GPLs) typical of M. avium spp that define serovar specificity and colony morphology; trehalose based lipids such as acylated trehaloses (containing straight chain, mycerocerosic acids, mycolipanolic and mycolipenic fatty acids) and sulpholipids (trehalose 2' sulphate acylated with phthioceranic and hydroxyphthioceranic acids) present in strains of M. tuberculosis; and lipooligosaccharides (LOSs) isolated from several species are absent in M. leprae. Instead, the dominant lipid is the phenolic glycolipid PGL-l 33 , a glycosylated derivative of the phenolphthiocerol dimycocerosate. The trisaccharide-of PGL-
and is highly antigenic. Synthetic glycoconjugates containing this trisaccharide are sensitive tools for serodiagnostics of leprosy. 34 Recently the trisaccharide was shown to be involved in the specific interaction of M. leprae with the laminin of Schwann ce1ls. 35 This discovery is an important step towards the identification of a mechanism for entry of M. leprae into nerve cells that can initiate the subsequent nerve damage that is the hallmark of leprosy. M. tuberculosis H37Rv contains only phthiocerol dimycocerosates. 8
Biosynthesis and genetics of cell wall (envelope) in M. leprae: insights from the genome sequence
The biosynthetic pathway for the individual components and their assembly to form the mAGP complex, as deciphered from the approaches mentioned before, is depicted in Figure 1 . ln the recent review by Crick et ai. 14 , only the 13 M. tuberculosis genes for AGP synthesis that have been functionally characterized have been highlighted. Eleven of these were identified by the 'cloning by homology' approach. ln Table 1 , we show the homologs for these genes in M. leprae. We predict that these genes will be functional in M. leprae without the need for their functional characterization as the homology is high, and genetic context is similar. Furthermore, we have included putative genes for reactions not yet characterized in mycobacteria, by finding homologs for known genes in other organisms using the BLAST algorithm ? 6 The genes for the mycolic acid and phenolphthiocerol dimycocerosate synthesis are also included. ln the following section, some of the biosynthetic pathways are described in brief. The common names of the genes involved are indicated in italic font in parenthesis.
My colic acid transfe r
Mycolic acids Table 1 . Polyprenyl-phosphate linked biosynthetic intermediates have been underlined. 5aa represents tbe pentapeptide linked to MurNGly in PG syntbesis. The Myc-X represents mycolic acid esterified to an unknown carrier. Myc-Man-P-C 50 is a polyprenyl-phosphate linked mycolate, shown to be involved in transport of mycolic acids through tbe membrane for deposition on AG (Besra et ai, Proe Natl Aead Sei USA , 1994, 91: 12735-12739).
PEPTIDOGL YCAN
The basic peptidoglycan biosynthetic machinery is similar to E. coZi and appears to be remarkably well preserved in M. tubercuZosis 1 3 , 1 4 and M. Zeprae. The main events are the synthesis of the unusual sugar-nuc1eotide UDP-MurNAc from UDP-GlcNAc (murA, murB), the sequential addition of five amino acids to the MurNAc (mure, murV, murE and murF), transfer of the sugar-pentapeptide to a polyprenyl-phosphate carrier (murX), followed by attachment of GlcNAC from UDP-GlcNAc (murG). Since the M. leprae peptidoglycan has glycine rather than L-alanine in the peptide cross links, it was thought there rnight be a genetic basis for this substitution. Mahapatra et al ? 9 analysed the genome but could not find a second ligase gene. ln fact they demonstrated by in vitro studies with the recombinant Mure enzyme, that it can use L-alanine or glycine substrate with comparable affinities. Therefore the presence of glycine in M. leprae is perhaps an in vivo phenomenon driven by the ambient arnino acid rnilieu.
ARABINOGA LACTAN
The synthesis of AG requires the sugar donors UDP-G1cNAc, 4o TDP-rhamnose (rrnIA, rrnlB, rrnlC and rrnlD) 40 , 4 1 , UDP-galactofuranose UDP-gal f (galE and glf ) 4 2 and decaprenyl phospho-arabinose DPA. 4 3 Successive addition of G1cNAc (rfe), rharnnose (wbbl), galacto furanose and arabinofuranose on a prenyl-phosphate lipid carrier 44 occurs before the entire LU-AG is transferred (ligated) to approximately 1 in 10 MurNAc units of peptidoglycan.
The synthesis of DPA is interesting and is proposed to originate from the pentose phosphate pathway as phosphoribose pyrophosphate (PRPP). 4 5 Epimerization of the ribose to arabinose may occur before or after transfer to a decaprenyl-phosphate carrier. Regarding the galactosyltransferases, Mikusova et al. 44 showed that the gene Rv3808c (glfI) of M. tuberculosis, is a galactosyltransferase in AG synthesis. There is an ortholog in M. leprae. Furthermore, Kremer et al. 46 suggest that it encodes a bi-functional transferase for the alternating 5 and 6 linked galactose residues of the galactan by use of synthetic acceptors. It has not been demonstrated if GIIT can also catalyse the addition of the first galactose unit to the rhamnose sugar of the linker unit and the second galactose of the galactan. GIIT contains the sugar nucleotide binding motif hhhhDxDxh where 'h' represents an arnino acid with hydrophobic nature.
With regard to arabinosyltransferases, the work of Belanger 47 suggests that the embA or embB genes of M. avium encode putative transferases for AG. A third gene, embC, also exists in all mycobacteria sequenced thus far and Escuyer et a!. 48 have shown that knocking out the embA or embB genes of M. smegmatis causes changes in the arabinan content and structure of AG. These Emb proteins are very homologous to each other; they are large and hydrophobic, and span membranes. The genes are well conserved amongst many mycobacteria and are intact in M. leprae in a gene c1uster very similar to that seen in M. tuberculosis. However, the proteins they encode have no significant homology to any other proteins in the database and no known domains or motifs. It is not c1ear if the Emb proteins are involved in the actual glycosyltransferase catalysis or in the assembly of the arabinan.
PRENYL· PHOS PHATE CARRIERS
The biosynthesis of many of the key cell wall polymers requires prenyl-phosphate carriers as sugar donors (DPM and DPA) and for carriers of the intermediates of cell wall polysaccharide synthesis (AG and PG). 14 The synthesis begins with the formation of deoxyxylulose phosphate from pyruvate and glyceraldehydes-3P (dxs-l), which is converted to the 5carbon isoprene compounds isopentenyl pyrophosphate (!PP) and its isomer dimethylallyl pyrophosphate (DMAPP) by the non-mevalonate pathway, also called the 2-C-methyl-o erythritol 4-phosphate (MEP) pathway. 49 ln M. tuberculosis there are two possible genes for this function (dxs-I and dxs-Il) . DXS-I has been shown to be functional by expression in E. coZi. sO Studies on DXS-Il, are in progresso However, dxs-Il may be redundant in M. tuberculosis, since the M. leprae genome has only one gene that is homologous to dxs I. The complete pathway for the synthesis of !PP and DMAPP is not known. However, for all genes identified in E. coli s l . s2 , homologous genes have been found in M. tuberculosis and M. leprae for this essential pathway. A non-essential IPP isomerase (idi) for the inter conversion of IPP and DMAPP is present in E. coU S3 and M. tuberculosis but not in M. leprae. The gene responsible for condensation of IPP with DMAP, to form geranyl diphosphate (GPP, C L O -PP) has not been identified in any organismo The addition of IPP to GPP results in famesyl diphosphate (FPP, C I S -PP), which is subsequently elongated by seven cyc1es of polymerization to form decaprenyl diphosphate in a specific stereochem istry in M. tuberculosis s4 and also probably in M. leprae because homologous polymerase genes exist. ln terms of synthesis of other isoprenoids, there are no homologs in M. leprae for four other prenyldiphosphate synthase genes found in the M. tuberculosis genome, except for the grcCl gene, which may be involved in the transfer of a prenyl moiety in the menaquinone pathway. There are also no homologs in M. leprae for the M. tuberculosis squalene synthase, monoxygenase and cyc1ase genes probably involved in steroid synthesis.
Biosynthesis of PI, PIMs, LM and LAM
The biosynthesis of phosphatidylinositol mannosides is initiated on the precursor PI using the gene product of pgsA SS , followed by mannosylation using GDP-mannose as the sugar donor. 56 Genes for a mannosyltransferase and an acyltransferase are linked to pgsA and may be required for the synthesis of PIM 1 and the acylation of mannose to form triacy! PIM), respectively. The gene product of Rv0557 (pimB) of M. tuberculosis has been identified as the second mannosyltransferase. s 7 The rPimB was shown to convert labeled tri-acylated PIM l to PIM 2 in the presence of GDP-mannose. PimB belongs to the family of glycosyltransferases that have a conserved C terminal motif EX 7 E. 58 This gene is a pseudogene in M. leprae and we predict that one of the other genes sharing a homologous active site is used (Table 1) . Subsequent mannosylation with undefined enzymes generates LM.
Of the many putative glycosyltransferases in the M. tuberculosis genome, several (Rv0539, Rv0696, Rv 1781c, Rv 1 500, Rv I513, Rv 1514c, Rv 1516c, Rv 1518, Rv 1 520 and Rv 1525) do not have orthologs in M. leprae. We propose that these enzymes are not involved in the biosynthesis of mannan, arabinan and galactan, since there are no significant structural differences between these molecules in M. tuberculosis and M. leprae.
Mycolic acids, TMM and TDM and deposition on AG
The synthesis of mycolates occurs in several stages: synthesis of the a-alkyl chain and the primer for the meromycolic acid by the multifunctional fatty acyl synthase FASI enzyme (ja si 9 ; linking by the ,a-keto acyl synthase III (ja bH) 60 and elongation of the primer l 1 by the disassociated fatty acyl synthase complex FASII (accD6, fa bD, kasA, kasB, acpM, mabA, inhA); 6l , 62 modification of the meromycolic acid (introduction of double bonds, cyclopro pane rings, keto, methyl and methoxy groups), probably in paralIel with elongation; 63 and finalIy condensation of the a-alkyl chain and meromycolate. The condensation step and the carrier on which this reaction occurs are not known. The mycolates are then transfeITed to AG and trehalose to forrn mAGP and TMMffDM respectively and may occur using the mycolyltransferases encoded by the members of the antigen 85 complex (jbpA, fbpB and fbpC2) 64 , 65 . All of these steps have been characterized in M. tuberculosis and homologs for the genes are present in M. leprae, with the exception of the gene encoding the linking enzyme FabH. The mechanism in M. leprae is not clear.
Phenolic glycolipids PGLs (glycosylphenolpthiocerol dimycocerosates)
The phthiocerol moiety is synthesized using a set of multifunctional enzymes (ppsA, ppsB, ppsC, ppsD and ppsE ) that contain one or more of the acyltransferase, ketoacyl synthase, keto reductase, dehydratase, enoyl reductase and acyl carrier modules for the polymerization of malonyl-CoA and methylmalonyl-CoA units on a C 22 -CoA fatty acid precursor. 66 Mycocerosic acid syntheisis occurs by the elongation of fatty acyl-CoA primers with methylmalonyl-CoA 67 (mas), folIowed by the transfer to the phthiocerol using a specific acyl-CoA synthase (ja dD28). Two membrane associated proteins MmpL7 and DITC have been shown to be responsible for the transport of the PDIM. ln M. tuberculosis, genes for alI these functions are clustered on the genome and mutations in these genes result in disruption of PDIM synthesis and loss of virulence. 68 ln M. leprae, the ppsA -E genes are intact but have been separated from the mas,fadD28 and mmpL7 genes. For the addition of the first rhamnose in the trisaccharide of PGL-l in M. leprae, we have analyzed the genome for genes homologous to the rharnn osyltransferases such as rifA of M. avium (for addition of L rhamnose to the 6-deoxy talose in GPL synthesis 69 ), and the wbbL gene of M. tuberculosis (involved in linker unit synthesis). Based on homology searches with rifA, we have identified the gene ML2348 in M. leprae as a candidate. Co-incidentally, ML2348 is located where the phthiocerol gene c1uster of pps/drr/papA5 has separated from the mas/fa dD28/ mmpL7 in M. leprae and may indicate its role in PGL-l. ML2348 is also homologous to genes used for the synthesis of glycosylated steroids in plants, and for antibiotics such as balhimycin and tylosin (tyIN, 6-deoxyalIosyltransferase) in microbes. 70 AlI these homologs use sterol/phenol like acceptors. Furtherrnore, rifA and tylN encode glycosyltransferases for sugars other than glucose (particularly 6-deoxy hexoses). Combining these pieces of inforrnation, we propose that ML2348 is a good candidate for the enzyme that transfers the first rhamnose. We postulate that the genes ML0 125 and ML0 128 are glycosyltrans ferases aud ML0 127 and ML0 130 are methylases for the synthesis of the second and third sugars of PGL-l. These genes are located c10se to the mycocerosoic acid gene c1uster mas/ fa dD28/m mpL7 genes. Genes that are highly homologous to ML2348 are also present in M. tuberculosis (RV1524 and 1526c). However, these are c1ustered with another pks system (Pks5). There are also homologs in M. tuberculosis for the candidate glycosyltransferases (Rv2958c and Rv2962c) and methyltransferases (RV 2952 and Rv2959c) in a c1uster similar to that in M. leprae, but may have no function since only phthiocerols and not the phenolpthiocerols are found in M. tuberculosis. 8
Concluding remarks
ln this review, we have identified putative genes of M. leprae for some biosynthetic pathways by homology searches with known genes of other organisms. We are comfortable with the premise that the genome of M. leprae approaches a minimal and perhaps also an 'essential' gene set for alI basic structural and biological properties shared by virulent and avirulent mycobacteria, particularly for celI walI core synthesis. Genes for the synthesis of precursor molecules that cannot be obtained from the host environment such as UDP-Gal f and TDP-Rha for AG, PI for PIMs, LM and LAM and DXP for polyprenyl phosphates have been retained in M. leprae. ln terrns of the practical approaches to verifying and harnessing this genetic inforrnation, recombinant proteins can be purified and used in suitable assays. ln the future, it may even be possible to set up de novo synthesis of complex macromolecules in crude extracts of M. leprae, since viable and high titre M. leprae are now available from nude mouse foot pads. 7 1 ln addition, M. leprae from this source have been kept viable for up to 6 weeks in broth culture at 30°C. Since the number of functional ORFs is smaller thau M. tuberculosis, use of microarrays and comparative proteomics, is a reasonable approach to identify genes that are preferentially regulated under defined and modified test conditions in vitro. We believe the M. leprae sequence inforrnation will be valuable towards efforts for elimination of leprosy.
